Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara A Mosley

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Advances in Experimental Medicine and Biology|June 16, 2007
Highly active anticancer curcumin analoguesCara A Mosley, Dennis C Liotta, James P Snyder
Expert Opinion on Therapeutic Patents|May 16, 2009
Recent patents regarding the discovery of small molecule CXCR4 antagonistsCara A Mosley, Lawrence J Wilson, John M Wiseman, et al.
Journal of Medicinal Chemistry|August 6, 2010
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonistsCara A Mosley, Timothy M Acker, Kasper B Hansen, et al.
Journal of Drug Targeting|March 28, 2008
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIaMamoru Shoji, Aiming Sun, Walter Kisiel, et al.
Bioorganic & Medicinal Chemistry|August 4, 2009
Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptorsCara A Mosley, Scott J Myers, Ernest E Murray, et al.
ACS Chemical Neuroscience|October 19, 2017
A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal InterneuronsSharon A Swanger, Katie M Vance, Timothy M Acker, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|June 16, 2007
Highly active anticancer curcumin analoguesCara A Mosley, Dennis C Liotta, James P Snyder
Expert Opinion on Therapeutic Patents|May 16, 2009
Recent patents regarding the discovery of small molecule CXCR4 antagonistsCara A Mosley, Lawrence J Wilson, John M Wiseman, et al.
Journal of Medicinal Chemistry|August 6, 2010
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonistsCara A Mosley, Timothy M Acker, Kasper B Hansen, et al.
Journal of Drug Targeting|March 28, 2008
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIaMamoru Shoji, Aiming Sun, Walter Kisiel, et al.
Bioorganic & Medicinal Chemistry|August 4, 2009
Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptorsCara A Mosley, Scott J Myers, Ernest E Murray, et al.
ACS Chemical Neuroscience|October 19, 2017
A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal InterneuronsSharon A Swanger, Katie M Vance, Timothy M Acker, et al.
Pageof 1